Editorial Article
Why bioassay validation is no longer the finish line for biologics
A validated bioassay that worked yesterday is not guaranteed to work tomorrow, and CRO Prolytix is urging the industry to rethink what ‘validated’ really means
Through extensive research, experimentation, and clinical trials, experts in the field of drug discovery and development identify promising biopharmaceutical or pharmaceutical drug candidates, optimize their efficacy and safety profiles, and navigate regulatory processes for eventual market approval. From innovative therapies to groundbreaking treatments, this dynamic scientific field plays a pivotal role in revolutionizing medicine and saving lives.
A validated bioassay that worked yesterday is not guaranteed to work tomorrow, and CRO Prolytix is urging the industry to rethink what ‘validated’ really means